{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:03:32Z","timestamp":1747181012408,"version":"3.40.5"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,5]]},"abstract":"<jats:p>This study aimed to evaluate the short-term morbidities and efficacy of single-dose prophylactic intravenous ibuprofen for patent ductus arteriosus (PDA) on the first day of life in preterm infants.<\/jats:p>\n          <jats:p>Data of 69 preterm infants with birth weight &lt; 1250\u2009g and gestational age &lt; 30 weeks admitted to the neonatal intensive care unit were analyzed. Of these, 37 infants were assigned to the prophylactic treatment (PT) group and 32 were assigned to the nonprophylactic treatment (non-PT) group. Only the PT group administered intravenous ibuprofen (10\u2009mg\/kg) once within 6 hours after birth.<\/jats:p>\n          <jats:p>Until postnatal day 7, ductal closure occurred in 11 (34.4%) infants in the non-PT group, and in 35 (94.6%) infants in the PT group, of which 30 (81.1%) infants had ductal closure on postnatal day 1. There were 2 (5.4%) infants in the PT group and 9 (28.1%) in the non-PT group who needed ibuprofen treatment due to moderate-to-large PDA after postnatal day 7. Preterm infants in the PT group were less likely to develop an intraventricular hemorrhage (\u2265grade 2) (adjusted odds ratio 0.007, 95% confidence interval 0.01\u20130.45), had a shorter duration of invasive ventilatory support and central venous catheter, and earlier postnatal age to achieve feeding of 50 and 100\u2009mL\/kg\/day compared with those in the non-PT group.<\/jats:p>\n          <jats:p>Single-dose prophylactic intravenous ibuprofen on the first day of life decreased the occurrence of a persistent PDA and intraventricular hemorrhage (\u2265grade 2), and reduced the duration of invasive ventilatory support, central venous catheter use, and hospital stay.<\/jats:p>","DOI":"10.1097\/md.0000000000029915","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T14:05:33Z","timestamp":1660053933000},"page":"e29915","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Single-dose prophylactic ibuprofen therapy for patent ductus arteriosus in preterm infants"],"prefix":"10.1097","volume":"101","author":[{"given":"Chae Young","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Kyung Hee University School of Medicine, Seoul, Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0352-9722","authenticated-orcid":false,"given":"Sung-Hoon","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kyung Hee University School of Medicine, Seoul, Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1542\/neo.19-7-e394","article-title":"Diagnosis and management of patent ductus arteriosus","volume":"19","author":"Gillam-Krakauer","year":"2018","journal-title":"Neoreviews"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3389\/fped.2020.00516","article-title":"Molecular and mechanical mechanisms regulating ductus arteriosus Closure in preterm infants","volume":"8","author":"Ovali","year":"2020","journal-title":"Front Pediatr"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.semperi.2013.01.006","article-title":"The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia","volume":"37","author":"Clyman","year":"2013","journal-title":"Semin Perinatol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"e20162390","DOI":"10.1542\/peds.2016-2390","article-title":"Trends in patent ductus arteriosus diagnosis and management for very low birth weight infants","volume":"139","author":"Ngo","year":"2017","journal-title":"Pediatrics"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/pr.2016.166","article-title":"Trends and variation in management and outcomes of very low-birth-weight infants with patent ductus arteriosus","volume":"80","author":"Hagadorn","year":"2016","journal-title":"Pediatr Res"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1056\/NEJM200009073431009","article-title":"Ibuprofen and patent ductus arteriosus","volume":"343","author":"Clyman","year":"2000","journal-title":"N Engl J Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/sj.jp.7211465","article-title":"Patent ductus arteriosus: pathophysiology and management","volume":"26","author":"Hermes-DeSantis","year":"2006","journal-title":"J Perinatol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1542\/peds.2005-1528","article-title":"Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less","volume":"117","author":"Koch","year":"2006","journal-title":"Pediatrics"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1542\/neo.19-7-e394","article-title":"Diagnosis and management of patent ductus arteriosus","volume":"19","author":"Gillam-Krakauer","year":"2018","journal-title":"Neoreviews"},{"key":"R10-20250504","first-page":"CD000174","article-title":"Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants","volume":"2010","author":"Fowlie","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R11-20250504","first-page":"CD004213","article-title":"Ibuprofen for the prevention of patent ductus arteriosus in preterm and\/or low birth weight infants","volume":"1","author":"Ohlsson","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00431-016-2830-7","article-title":"Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates","volume":"176","author":"El-Mashad","year":"2017","journal-title":"Eur J Pediatr"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1053\/jpsu.2003.50086","article-title":"Patent ductus arteriosus in micropreemies and full-term infants: the relative merits of surgical ligation versus indomethacin treatment","volume":"38","author":"Little","year":"2003","journal-title":"J Pediatr Surg"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1542\/peds.2004-1178","article-title":"Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: a multicenter, randomized study","volume":"115","author":"Dani","year":"2005","journal-title":"Pediatrics"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s004310051288","article-title":"Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants","volume":"159","author":"De Carolis","year":"2000","journal-title":"Eur J Pediatr"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/S0140-6736(04)17476-X","article-title":"Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial","volume":"364","author":"Gournay","year":"2004","journal-title":"Lancet"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"F75","DOI":"10.1136\/adc.2004.058347","article-title":"Ibuprofen and cerebral oxygenation and circulation","volume":"90","author":"Naulaers","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00228-012-1438-8","article-title":"Serum ibuprofen levels of extremely preterm infants treated prophylactically with oral ibuprofen to prevent patent ductus arteriosus","volume":"69","author":"Kanmaz","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"R19-20250504","first-page":"788","article-title":"A comparison of early ibuprofen and indomethacin administration to prevent intraventricular hemorrhage among preterm infants","volume":"54","author":"Kalani","year":"2016","journal-title":"Acta Med Iran"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jpeds.2018.09.012","article-title":"PDA-TOLERATE (PDA: to leave it alone or Respond And Treat Early) Trial Investigators. PDA-TOLERATE Trial: an exploratory randomized controlled trial of treatment of moderate-to-large patent ductus arteriosus at 1 week of age","volume":"205","author":"Clyman","year":"2019","journal-title":"J Pediatr"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpeds.2018.06.045","article-title":"Relationship of patent ductus arteriosus size to echocardiographic markers of shunt volume","volume":"202","author":"de Freitas Martins","year":"2018","journal-title":"J Pediatr"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.siny.2018.03.007","article-title":"Role of neonatologist-performed echocardiography in the assessment and management of patent ductus arteriosus physiology in the newborn","volume":"23","author":"de Boode","year":"2018","journal-title":"Semin Fetal Neonatal Med"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40348-015-0013-7","article-title":"Bronchopulmonary dysplasia - an overview about pathophysiologic concepts","volume":"2","author":"Niedermaier","year":"2015","journal-title":"Mol Cell Pediatr"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41390-020-1074-4","article-title":"Defining necrotizing enterocolitis: current difficulties and future opportunities","volume":"88","author":"Patel","year":"2020","journal-title":"Pediatr Res"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5001\/omj.2010.49","article-title":"An overview of clinical pharmacology of Ibuprofen","volume":"25","author":"Bushra","year":"2010","journal-title":"Oman Med. J"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0735-1097(02)01886-7","article-title":"The incidence of congenital heart disease","volume":"39","author":"Hoffman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pedneo.2019.10.002","article-title":"Therapeutic strategy of patent ductus arteriosus in extremely preterm infants","volume":"61","author":"Su","year":"2020","journal-title":"Pediatr Neonatol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jpeds.2017.03.021","article-title":"Prophylactic indomethacin compared with delayed conservative management of the patent ductus arteriosus in extremely preterm infants: effects on neonatal outcomes","volume":"187","author":"Liebowitz","year":"2017","journal-title":"J Pediatr"},{"key":"R29-20250504","first-page":"S28","article-title":"Prophylaxis of symptomatic patent ductus arteriosus with oral ibuprofen in very low birth weight infants","volume":"91","author":"Sangtawesin","year":"2008","journal-title":"J Med Assoc Thai"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/S0140-6736(02)08424-6","article-title":"Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants","volume":"359","author":"Gournay","year":"2002","journal-title":"Lancet"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jpeds.2016.08.103","article-title":"Pulmonary arterial hypertension after ibuprofen treatment for patent ductus arteriosus in very low birth weight infants","volume":"179","author":"Kim","year":"2016","journal-title":"J Pediatr"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1056\/NEJM200106283442602","article-title":"Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants","volume":"344","author":"Schmidt","year":"2001","journal-title":"N Engl J Med"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"626262","DOI":"10.3389\/fped.2021.626262","article-title":"Factors associated with benefit of treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis","volume":"9","author":"Jansen","year":"2021","journal-title":"Front Pediatr"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fped.2019.00408","article-title":"Intraventricular hemorrhage: risk factors and association with patent ductus arteriosus treatment in extremely preterm neonates","volume":"7","author":"Khanafer-Larocque","year":"2019","journal-title":"Front Pediatr"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1080\/14767058.2019.1667323","article-title":"Ibuprofen treatment after the first days of life in preterm neonates with patent ductus arteriosus","volume":"34","author":"de Klerk","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"F179","DOI":"10.1136\/fn.76.3.F179","article-title":"Treatment of patent ductus arteriosus with ibuprofen","volume":"76","author":"Van Overmeire","year":"1997","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3390\/nu11092029","article-title":"The influence of early nutrition on brain growth and neurodevelopment in extremely preterm babies: a narrative review","volume":"11","author":"Cormack","year":"2019","journal-title":"Nutrients"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"e0139014","DOI":"10.1371\/journal.pone.0139014","article-title":"Weight growth velocity and neurodevelopmental outcomes in extremely low birth weight infants","volume":"10","author":"Maruyama","year":"2015","journal-title":"PLoS One"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/2229-5151.134184","article-title":"Catheter-related bloodstream infections","volume":"4","author":"Gahlot","year":"2014","journal-title":"Int J Crit Illn Inj Sci"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-019-0127-7","article-title":"Bronchopulmonary dysplasia","volume":"5","author":"Th\u00e9baud","year":"2019","journal-title":"Nat Rev Dis Primers"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:28:44Z","timestamp":1746332924000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":40,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029915","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,8,5]]}}}